{"id":6291,"date":"2022-12-14T11:39:43","date_gmt":"2022-12-14T10:39:43","guid":{"rendered":"https:\/\/www.boldbrain.ch\/?p=6291"},"modified":"2025-02-10T11:43:24","modified_gmt":"2025-02-10T10:43:24","slug":"boldbrain-will-be-at-start-summit-2023","status":"publish","type":"post","link":"https:\/\/www.boldbrain.ch\/en\/boldbrain-will-be-at-start-summit-2023\/","title":{"rendered":"AliperTherapeutics wins the fifth edition"},"content":{"rendered":"<p>At the Palazzo dei Congressi in Lugano, the final of the fifth edition took place. Among the finalists, AliperTharapeutics, a start-up created as a spinoff of the Institute for Research in Oncology (IOR) in Bellinzona with the aim of developing pharmacological treatments for prostate cancer, won the first prize from the national jury. The audience prize was instead awarded to Revozona, which also won fifth place from the jury. Using a special ozone gas process to clean raw fabrics, it saves 90% in CO2 emissions and water use and reduces the use of energy and chemicals by 40%. In second place was AQUAtryp\u00ae, in third place ZARIO, and in fourth place GiPSy, which also won a special prize from Hemargroup. The Agire Foundation awarded its desks at the Tecnopolo Ticino, for one year, to FormidAbile, Revozona and Zario.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>At the Palazzo dei Congressi in Lugano, the final of the fifth edition took place. Among the finalists, AliperTharapeutics, a start-up created as a spinoff of the Institute for Research in Oncology (IOR) in Bellinzona with the aim of developing pharmacological treatments for prostate cancer, won the first prize from the national jury. The audience prize was instead awarded to Revozona, which also won fifth place from the jury. Using a special ozone gas process to clean raw fabrics, it saves 90% in CO2 emissions and water use and reduces the use of energy and chemicals by 40%. In second place was AQUAtryp\u00ae, in third place ZARIO, and in fourth place GiPSy, which also won a special prize from Hemargroup. The Agire Foundation awarded its desks at the Tecnopolo Ticino, for one year, to FormidAbile, Revozona and Zario.<\/p>\n","protected":false},"author":1,"featured_media":6297,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[110],"tags":[91,92,93],"class_list":["post-6291","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en-3","tag-accelerator-en","tag-innovation-en","tag-startup-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AliperTherapeutics wins the fifth edition - Boldbrain Startup Challenge<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.boldbrain.ch\/en\/boldbrain-will-be-at-start-summit-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AliperTherapeutics wins the fifth edition - Boldbrain Startup Challenge\" \/>\n<meta property=\"og:description\" content=\"At the Palazzo dei Congressi in Lugano, the final of the fifth edition took place. Among the finalists, AliperTharapeutics, a start-up created as a spinoff of the Institute for Research in Oncology (IOR) in Bellinzona with the aim of developing pharmacological treatments for prostate cancer, won the first prize from the national jury. The audience prize was instead awarded to Revozona, which also won fifth place from the jury. Using a special ozone gas process to clean raw fabrics, it saves 90% in CO2 emissions and water use and reduces the use of energy and chemicals by 40%. In second place was AQUAtryp\u00ae, in third place ZARIO, and in fourth place GiPSy, which also won a special prize from Hemargroup. The Agire Foundation awarded its desks at the Tecnopolo Ticino, for one year, to FormidAbile, Revozona and Zario.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.boldbrain.ch\/en\/boldbrain-will-be-at-start-summit-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Boldbrain Startup Challenge\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/BoldbrainCH\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-14T10:39:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-10T10:43:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.boldbrain.ch\/wp-content\/uploads\/2025\/02\/Boldbrain_finale_2022_1-1024x683.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"683\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"bold-adm\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BoldbrainCH\" \/>\n<meta name=\"twitter:site\" content=\"@BoldbrainCH\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"bold-adm\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/boldbrain-will-be-at-start-summit-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/boldbrain-will-be-at-start-summit-2023\\\/\"},\"author\":{\"name\":\"bold-adm\",\"@id\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/#\\\/schema\\\/person\\\/537b3e06456c8689971387f961b0351d\"},\"headline\":\"AliperTherapeutics wins the fifth edition\",\"datePublished\":\"2022-12-14T10:39:43+00:00\",\"dateModified\":\"2025-02-10T10:43:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/boldbrain-will-be-at-start-summit-2023\\\/\"},\"wordCount\":141,\"publisher\":{\"@id\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/boldbrain-will-be-at-start-summit-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.boldbrain.ch\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/Boldbrain_finale_2022_1.jpg\",\"keywords\":[\"Accelerator\",\"Innovation\",\"Startup\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/boldbrain-will-be-at-start-summit-2023\\\/\",\"url\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/boldbrain-will-be-at-start-summit-2023\\\/\",\"name\":\"AliperTherapeutics wins the fifth edition - Boldbrain Startup Challenge\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/boldbrain-will-be-at-start-summit-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/boldbrain-will-be-at-start-summit-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.boldbrain.ch\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/Boldbrain_finale_2022_1.jpg\",\"datePublished\":\"2022-12-14T10:39:43+00:00\",\"dateModified\":\"2025-02-10T10:43:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/boldbrain-will-be-at-start-summit-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/boldbrain-will-be-at-start-summit-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/boldbrain-will-be-at-start-summit-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.boldbrain.ch\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/Boldbrain_finale_2022_1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.boldbrain.ch\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/Boldbrain_finale_2022_1.jpg\",\"width\":7726,\"height\":5151,\"caption\":\"Lugano: Boldbrain 2022, Cerimonia Finale. Nella foto il gruppoo di vintori con Nicol\u00f2 Pernigoni di AliperTherapeutics vincitore del primo premio. \u00a9 Ti-Press \\\/ Pablo Gianinazzi\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/boldbrain-will-be-at-start-summit-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AliperTherapeutics wins the fifth edition\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/\",\"name\":\"Boldbrain\",\"description\":\"Startup accelerator\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/#organization\",\"name\":\"Boldbrain\",\"url\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.boldbrain.ch\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/boldbrain_logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.boldbrain.ch\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/boldbrain_logo.svg\",\"caption\":\"Boldbrain\"},\"image\":{\"@id\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/BoldbrainCH\",\"https:\\\/\\\/x.com\\\/BoldbrainCH\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/boldbrain\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC5VCf0nTgYAWzX0qAdtZ72g\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/#\\\/schema\\\/person\\\/537b3e06456c8689971387f961b0351d\",\"name\":\"bold-adm\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a33917c789af4748c29c80aaf9c626d377bf69055afb251cd241d35ad0be09d8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a33917c789af4748c29c80aaf9c626d377bf69055afb251cd241d35ad0be09d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a33917c789af4748c29c80aaf9c626d377bf69055afb251cd241d35ad0be09d8?s=96&d=mm&r=g\",\"caption\":\"bold-adm\"},\"sameAs\":[\"https:\\\/\\\/www.boldbrain.ch\"],\"url\":\"https:\\\/\\\/www.boldbrain.ch\\\/en\\\/author\\\/bold-adm\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AliperTherapeutics wins the fifth edition - Boldbrain Startup Challenge","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.boldbrain.ch\/en\/boldbrain-will-be-at-start-summit-2023\/","og_locale":"en_US","og_type":"article","og_title":"AliperTherapeutics wins the fifth edition - Boldbrain Startup Challenge","og_description":"At the Palazzo dei Congressi in Lugano, the final of the fifth edition took place. Among the finalists, AliperTharapeutics, a start-up created as a spinoff of the Institute for Research in Oncology (IOR) in Bellinzona with the aim of developing pharmacological treatments for prostate cancer, won the first prize from the national jury. The audience prize was instead awarded to Revozona, which also won fifth place from the jury. Using a special ozone gas process to clean raw fabrics, it saves 90% in CO2 emissions and water use and reduces the use of energy and chemicals by 40%. In second place was AQUAtryp\u00ae, in third place ZARIO, and in fourth place GiPSy, which also won a special prize from Hemargroup. The Agire Foundation awarded its desks at the Tecnopolo Ticino, for one year, to FormidAbile, Revozona and Zario.","og_url":"https:\/\/www.boldbrain.ch\/en\/boldbrain-will-be-at-start-summit-2023\/","og_site_name":"Boldbrain Startup Challenge","article_publisher":"https:\/\/www.facebook.com\/BoldbrainCH","article_published_time":"2022-12-14T10:39:43+00:00","article_modified_time":"2025-02-10T10:43:24+00:00","og_image":[{"width":1024,"height":683,"url":"https:\/\/www.boldbrain.ch\/wp-content\/uploads\/2025\/02\/Boldbrain_finale_2022_1-1024x683.jpg","type":"image\/jpeg"}],"author":"bold-adm","twitter_card":"summary_large_image","twitter_creator":"@BoldbrainCH","twitter_site":"@BoldbrainCH","twitter_misc":{"Written by":"bold-adm","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.boldbrain.ch\/en\/boldbrain-will-be-at-start-summit-2023\/#article","isPartOf":{"@id":"https:\/\/www.boldbrain.ch\/en\/boldbrain-will-be-at-start-summit-2023\/"},"author":{"name":"bold-adm","@id":"https:\/\/www.boldbrain.ch\/en\/#\/schema\/person\/537b3e06456c8689971387f961b0351d"},"headline":"AliperTherapeutics wins the fifth edition","datePublished":"2022-12-14T10:39:43+00:00","dateModified":"2025-02-10T10:43:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.boldbrain.ch\/en\/boldbrain-will-be-at-start-summit-2023\/"},"wordCount":141,"publisher":{"@id":"https:\/\/www.boldbrain.ch\/en\/#organization"},"image":{"@id":"https:\/\/www.boldbrain.ch\/en\/boldbrain-will-be-at-start-summit-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.boldbrain.ch\/wp-content\/uploads\/2025\/02\/Boldbrain_finale_2022_1.jpg","keywords":["Accelerator","Innovation","Startup"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.boldbrain.ch\/en\/boldbrain-will-be-at-start-summit-2023\/","url":"https:\/\/www.boldbrain.ch\/en\/boldbrain-will-be-at-start-summit-2023\/","name":"AliperTherapeutics wins the fifth edition - Boldbrain Startup Challenge","isPartOf":{"@id":"https:\/\/www.boldbrain.ch\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.boldbrain.ch\/en\/boldbrain-will-be-at-start-summit-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.boldbrain.ch\/en\/boldbrain-will-be-at-start-summit-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.boldbrain.ch\/wp-content\/uploads\/2025\/02\/Boldbrain_finale_2022_1.jpg","datePublished":"2022-12-14T10:39:43+00:00","dateModified":"2025-02-10T10:43:24+00:00","breadcrumb":{"@id":"https:\/\/www.boldbrain.ch\/en\/boldbrain-will-be-at-start-summit-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.boldbrain.ch\/en\/boldbrain-will-be-at-start-summit-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.boldbrain.ch\/en\/boldbrain-will-be-at-start-summit-2023\/#primaryimage","url":"https:\/\/www.boldbrain.ch\/wp-content\/uploads\/2025\/02\/Boldbrain_finale_2022_1.jpg","contentUrl":"https:\/\/www.boldbrain.ch\/wp-content\/uploads\/2025\/02\/Boldbrain_finale_2022_1.jpg","width":7726,"height":5151,"caption":"Lugano: Boldbrain 2022, Cerimonia Finale. Nella foto il gruppoo di vintori con Nicol\u00f2 Pernigoni di AliperTherapeutics vincitore del primo premio. \u00a9 Ti-Press \/ Pablo Gianinazzi"},{"@type":"BreadcrumbList","@id":"https:\/\/www.boldbrain.ch\/en\/boldbrain-will-be-at-start-summit-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.boldbrain.ch\/en\/"},{"@type":"ListItem","position":2,"name":"AliperTherapeutics wins the fifth edition"}]},{"@type":"WebSite","@id":"https:\/\/www.boldbrain.ch\/en\/#website","url":"https:\/\/www.boldbrain.ch\/en\/","name":"Boldbrain","description":"Startup accelerator","publisher":{"@id":"https:\/\/www.boldbrain.ch\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.boldbrain.ch\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.boldbrain.ch\/en\/#organization","name":"Boldbrain","url":"https:\/\/www.boldbrain.ch\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.boldbrain.ch\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.boldbrain.ch\/wp-content\/uploads\/2023\/11\/boldbrain_logo.svg","contentUrl":"https:\/\/www.boldbrain.ch\/wp-content\/uploads\/2023\/11\/boldbrain_logo.svg","caption":"Boldbrain"},"image":{"@id":"https:\/\/www.boldbrain.ch\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/BoldbrainCH","https:\/\/x.com\/BoldbrainCH","https:\/\/www.linkedin.com\/company\/boldbrain","https:\/\/www.youtube.com\/channel\/UC5VCf0nTgYAWzX0qAdtZ72g"]},{"@type":"Person","@id":"https:\/\/www.boldbrain.ch\/en\/#\/schema\/person\/537b3e06456c8689971387f961b0351d","name":"bold-adm","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a33917c789af4748c29c80aaf9c626d377bf69055afb251cd241d35ad0be09d8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a33917c789af4748c29c80aaf9c626d377bf69055afb251cd241d35ad0be09d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a33917c789af4748c29c80aaf9c626d377bf69055afb251cd241d35ad0be09d8?s=96&d=mm&r=g","caption":"bold-adm"},"sameAs":["https:\/\/www.boldbrain.ch"],"url":"https:\/\/www.boldbrain.ch\/en\/author\/bold-adm\/"}]}},"_links":{"self":[{"href":"https:\/\/www.boldbrain.ch\/en\/wp-json\/wp\/v2\/posts\/6291","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.boldbrain.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.boldbrain.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.boldbrain.ch\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.boldbrain.ch\/en\/wp-json\/wp\/v2\/comments?post=6291"}],"version-history":[{"count":3,"href":"https:\/\/www.boldbrain.ch\/en\/wp-json\/wp\/v2\/posts\/6291\/revisions"}],"predecessor-version":[{"id":6305,"href":"https:\/\/www.boldbrain.ch\/en\/wp-json\/wp\/v2\/posts\/6291\/revisions\/6305"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.boldbrain.ch\/en\/wp-json\/wp\/v2\/media\/6297"}],"wp:attachment":[{"href":"https:\/\/www.boldbrain.ch\/en\/wp-json\/wp\/v2\/media?parent=6291"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.boldbrain.ch\/en\/wp-json\/wp\/v2\/categories?post=6291"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.boldbrain.ch\/en\/wp-json\/wp\/v2\/tags?post=6291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}